SCHEMBL8093987

SCHEMBL8093987

N#Cc1cc(-c2ccc(S(N)(=O)=O)cc2)c(-c2ccc(F)cc2)nc1NCc1ccncc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 7/20 0.48
RET P07949 1/20 0.45
ALOX5 P09917 1/20 0.44
PTGS1 P23219 2/20 0.41
CA2 P00918 5/20 0.41
CA1 P00915 4/20 0.41
CA9 Q16790 3/20 0.41
CA12 O43570 2/20 0.41
CDK1 P06493 1/20 0.40
KDR P35968 1/20 0.40
MAPK13 O15264 1/20 0.40
MAPK12 P53778 1/20 0.40
MAPK11 Q15759 1/20 0.40
MAPK14 Q16539 1/20 0.40
CNR1 P21554 1/20 0.40
CNR2 P34972 1/20 0.40
CA7 P43166 1/20 0.40
CA13 Q8N1Q1 1/20 0.40
IKBKB O14920 1/20 0.39
CHUK O15111 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8099266 0.90 PTGS2 (0.53) PTGS2ALOX5PTGS1MAPK13MAPK12
SCHEMBL8094187 0.90 CNR1 (0.50) PTGS2CA2CA1CA9CA12
SCHEMBL8085724 0.87 PTGS2 (0.51) PTGS2PTGS1CA2CA1CA9
SCHEMBL8092536 0.85 PTGS2 (0.43) PTGS2PTGS1CA2CA1CA9
SCHEMBL8086911 0.83 HPGD (0.45) PTGS2PTGS1CA2CA1CA9
SCHEMBL8086615 0.83 PTGS2 (0.49) PTGS2PTGS1CA2CA1CA9
SCHEMBL8099660 0.83 MAPT (0.49) PTGS2PTGS1CA2CA1CA9
SCHEMBL8094849 0.83 HPGD (0.48) PTGS2PTGS1CA2CA1CA9
SCHEMBL8094996 0.80 PTGS2 (0.48) PTGS2PTGS1CA2CA1CA9
SCHEMBL8101771 0.80 PTGS2 (0.54) PTGS2PTGS1MAPK13MAPK12MAPK11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0808304-B1 2,3-SUBSTITUTED PYRIDINES FOR THE TREATMENT OF INFLAMMATION SEARLE & CO (US) 2000-12-27 EP disclosed
EP-0808304-A1 2,3-SUBSTITUTED PYRIDINES FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1997-11-26 EP disclosed
WO-1996024584-A1 2,3-SUBSTITUTED PYRIDINES FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1996-08-15 WO disclosed